Real-world analysis confirms tirzepatide efficacy in HFpEF patients, validating clinical trial results in everyday clinical practice.
Key findingReal-world analysis confirms tirzepatide efficacy in HFpEF patients, validating clinical trial resul
What the researchers found
Real-world analysis confirms tirzepatide efficacy in HFpEF patients, validating clinical trial results in everyday clinical practice.
Why it matters
Relevant to peptide therapeutics.
How the study worked
In publication.
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
Real-world efficacy of tirzepatide in patients with heart failure without diabetes.
Current problems in cardiology, 50(4), 102998
Citation
Augusto, Silvio Nunes; Kaelber, David; Tang, W H Wilson. (2025). Real-world efficacy of tirzepatide in patients with heart failure without diabetes.. Current problems in cardiology, 50(4), 102998. https://doi.org/10.1016/j.cpcardiol.2025.102998